Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Treiber

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Arzneimittel-Forschung|January 1, 1997
Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradicationG Treiber, S Walker, U Klotz
Journal of Cancer Research and Clinical Oncology|July 22, 2008
Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancerG Treiber, T Wex, P Malfertheiner
Helicobacter|August 8, 2002
Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failuresG Treiber, S Ammon, P Malfertheiner, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2000
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pyloriS Ammon, G Treiber, F Kees, et al.
Helicobacter|April 18, 1998
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradicationG Treiber, S Ammon, E Schneider, et al.
Zeitschrift Fur Gastroenterologie|May 16, 2007
Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancerG Treiber, C Röcken, T Wex, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2009
Low-dose aspirin reduces the gene expression of gastrokine-1 in the antral mucosa of healthy subjectsG Martin, T Wex, G Treiber, et al.
Clinical Pharmacokinetics|August 1, 1993
Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerationsG Li, G Treiber, K Maier, et al.
Journal of Cancer Research and Clinical Oncology|July 13, 2006
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinomaG Treiber, T Wex, C Röcken, et al.
Klinische Wochenschrift|October 3, 1990
Gastric emptying in non-responders to H2-receptor antagonistsS Walker, J Meinke, U Klotz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Arzneimittel-Forschung|January 1, 1997
Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradicationG Treiber, S Walker, U Klotz
Journal of Cancer Research and Clinical Oncology|July 22, 2008
Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancerG Treiber, T Wex, P Malfertheiner
Helicobacter|August 8, 2002
Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failuresG Treiber, S Ammon, P Malfertheiner, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2000
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pyloriS Ammon, G Treiber, F Kees, et al.
Helicobacter|April 18, 1998
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradicationG Treiber, S Ammon, E Schneider, et al.
Zeitschrift Fur Gastroenterologie|May 16, 2007
Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancerG Treiber, C Röcken, T Wex, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2009
Low-dose aspirin reduces the gene expression of gastrokine-1 in the antral mucosa of healthy subjectsG Martin, T Wex, G Treiber, et al.
Clinical Pharmacokinetics|August 1, 1993
Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerationsG Li, G Treiber, K Maier, et al.
Journal of Cancer Research and Clinical Oncology|July 13, 2006
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinomaG Treiber, T Wex, C Röcken, et al.
Klinische Wochenschrift|October 3, 1990
Gastric emptying in non-responders to H2-receptor antagonistsS Walker, J Meinke, U Klotz, et al.
Pageof 4